Platt R - Search Results

1

Risk factors for statin-associated rhabdomyolysis.

Schech S, Graham D, Staffa J, Andrade SE, La Grenade L, Burgess M, Blough D, Stergachis A, Chan KA, Platt R, Shatin D. Schech S, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):352-8. doi: 10.1002/pds.1287. Pharmacoepidemiol Drug Saf. 2007. PMID: 16892458

2

Liver function testing in patients on HMG-CoA reductase inhibitors.

Andrade SE, Donahue JG, Chan KA, Watson DJ, Platt R. Andrade SE, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2003 Jun;12(4):307-13. doi: 10.1002/pds.832. Pharmacoepidemiol Drug Saf. 2003. PMID: 12812011

3

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz JH, Chan KA, Goodman MJ, Platt R. Graham DJ, et al. Among authors: platt r. JAMA. 2004 Dec 1;292(21):2585-90. doi: 10.1001/jama.292.21.2585. Epub 2004 Nov 22. JAMA. 2004. PMID: 15572716

4

Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis.

Andrade SE, Graham DJ, Staffa JA, Schech SD, Shatin D, La Grenade L, Goodman MJ, Platt R, Gurwitz JH, Chan KA. Andrade SE, et al. Among authors: platt r. J Clin Epidemiol. 2005 Feb;58(2):171-4. doi: 10.1016/j.jclinepi.2004.10.004. J Clin Epidemiol. 2005. PMID: 15680751

5

FDA drug prescribing warnings: is the black box half empty or half full?

Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. Wagner AK, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):369-86. doi: 10.1002/pds.1193. Pharmacoepidemiol Drug Saf. 2006. PMID: 16294363

6

Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R. Raebel MA, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):55-64. doi: 10.1002/pds.1217. Pharmacoepidemiol Drug Saf. 2007. PMID: 16470693

7

Asthma drug use and the development of Churg-Strauss syndrome (CSS).

Harrold LR, Patterson MK, Andrade SE, Dube T, Go AS, Buist AS, Chan KA, Weller PF, Wechsler ME, Yood RA, Davis KJ, Platt R, Walker AM. Harrold LR, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):620-6. doi: 10.1002/pds.1353. Pharmacoepidemiol Drug Saf. 2007. PMID: 17192840

8

Early detection of adverse drug events within population-based health networks: application of sequential testing methods.

Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Brown JS, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1275-84. doi: 10.1002/pds.1509. Pharmacoepidemiol Drug Saf. 2007. PMID: 17955500

9

Outpatient use of cardiovascular drugs during pregnancy.

Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Dal Pan GJ, Scott PE, Platt R. Andrade SE, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):240-7. doi: 10.1002/pds.1550. Pharmacoepidemiol Drug Saf. 2008. PMID: 18200619

10

Adverse events associated with prolonged antibiotic use.

Meropol SB, Chan KA, Chen Z, Finkelstein JA, Hennessy S, Lautenbach E, Platt R, Schech SD, Shatin D, Metlay JP. Meropol SB, et al. Among authors: platt r. Pharmacoepidemiol Drug Saf. 2008 May;17(5):523-32. doi: 10.1002/pds.1547. Pharmacoepidemiol Drug Saf. 2008. PMID: 18215001 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,194 results

Search Page